Calreticulin 3 Antikörper
-
- Target Alle Calreticulin 3 (CALR3) Antikörper anzeigen
- Calreticulin 3 (CALR3)
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser Calreticulin 3 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Spezifität
- Human CALR3
- Aufreinigung
- Protein A/G purified
- Immunogen
-
Full length human recombinant protein of human CALR3(NP_659483) produced in HEK293T cell.
Type of Immunogen: Recombinant protein - Klon
- 1D2
- Isotyp
- IgG1
- Top Product
- Discover our top product CALR3 Primärantikörper
-
-
- Applikationshinweise
- Approved: WB (1:4000)
- Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- PBS, pH 7.3, 1 % BSA, 50 % glycerol, 0.02 % sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Minimize freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze-thaw cycles.
-
- Target
- Calreticulin 3 (CALR3)
- Andere Bezeichnung
- CALR3 (CALR3 Produkte)
- Synonyme
- 1700031L01Rik antikoerper, 6330586I20Rik antikoerper, Crt2 antikoerper, cspn antikoerper, CMH19 antikoerper, CRT2 antikoerper, CT93 antikoerper, A. thaliana calreticulin 3 antikoerper, AtCRT3 antikoerper, CALRETICULIN 3 antikoerper, EBS2 antikoerper, EMS-MUTAGENIZED BRI1 SUPPRESSOR 2 antikoerper, PRIORITY IN SWEET LIFE 1 antikoerper, PSL1 antikoerper, T27G7.13 antikoerper, T27G7_13 antikoerper, calreticulin 3 antikoerper, CALR antikoerper, calreticulin 3 antikoerper, CALR3 antikoerper, Calr3 antikoerper, CRT3 antikoerper
- Hintergrund
-
Name/Gene ID: CALR3
Synonyms: CALR3, Calreticulin 3, Calreticulin-2, Calreticulin-3, Calsperin, CRT2, CT93, CMH19, Cancer/testis antigen 93 - Gen-ID
- 125972
- NCBI Accession
- NP_659483
- UniProt
- Q96L12
- Pathways
- Activation of Innate immune Response
-